About Us
Company Story
Shaped by decades of hands-on experience across scientific research and commercial innovation, LIVIUS advances a proprietary cellular reprogramming platform based on miRNA biology, small-molecule–driven epigenetic control, and DNA repair. By working with the cell’s inherent regulatory mechanisms, our approach enables controlled and scalable modulation of cellular state, forming a foundation for both scientific discovery and real-world application.
This integrated platform allows breakthrough research to translate seamlessly into tangible outcomes—from science-driven cosmetics and regulated non-prescription products to a growing therapeutic drug discovery pipeline. Headquartered in Singapore, with strategic operations in Japan and the United States, LIVIUS is positioned at the intersection of global research, clinical translation, and commercialization.
Our mission is to harness advanced biotechnology to improve human health and enrich lives by confronting some of medicine’s most persistent challenges. By uniting rigorous R&D with proven pathways to commercialization, we aim to build sustainable solutions that create lasting impact across healthcare.
Leadership
LIVIUS is led by a team that brings together deep scientific expertise and global business execution,
united by a shared commitment to translating advanced biotechnology into real-world impact.
Masaki Miyamoto
– Founder & Chairman
With a rich background in entrepreneurship and strategic business development, Masaki has been the visionary force behind LIVIUS. His ability to turn early setbacks into catalysts for innovation has propelled the company to the forefront of biotechnology. His deep industry insights ensure that LIVIUS not only leads in research but also in delivering commercially viable solutions.
Yoshihito Otani
– CEO & COO
A global business leader with extensive experience supporting the launch and growth of technology-driven companies across multiple markets. At LIVIUS, he oversees corporate strategy, business development, and global operations, bridging scientific innovation with scalable commercialization.
Milestones
Early Scientific Foundation
Established the scientific basis for miRNA-driven cellular reprogramming and DNA repair through foundational research, forming the core of LIVIUS’s technology platform.
Commercial Validation
Successfully developed and launched science-driven cosmetic and professional-use products, demonstrating real-world applicability of LIVIUS’s cellular reprogramming technology.
Global Operations Established
Headquartered in Singapore with strategic operational presence in Japan, China and the United States, enabling close integration of research, development, and commercialization across key markets.